MAPT and Alzheimer disease: Based on modern diagnosis criteria, three sets of biomarkers are used as diagnostic tools, including Aβ peptide (A), tau peptide (T) and neurodegeneration (N), which are classified as A/T/N framework (Table 1) of AD diagnosis [17].